HomeCompareHOLX vs KMI

HOLX vs KMI: Dividend Comparison 2026

HOLX yields 2.65% · KMI yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMI wins by $7.0K in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
KMI
KMI
● Live price
3.48%
Share price
$33.65
Annual div
$1.17
5Y div CAGR
12.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.6K
Annual income
$1,607.93
Full KMI calculator →

Portfolio growth — HOLX vs KMI

📍 KMI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXKMI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + KMI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
KMI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
KMI
Annual income on $10K today (after 15% tax)
$295.54/yr
After 10yr DRIP, annual income (after tax)
$1,366.74/yr
At 15% tax rate, KMI beats the other by $1,099.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + KMI for your $10,000?

HOLX: 50%KMI: 50%
100% KMI50/50100% HOLX
Portfolio after 10yr
$27.1K
Annual income
$960.98/yr
Blended yield
3.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HOLX right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
KMI
Analyst Ratings
16
Buy
17
Hold
1
Sell
Consensus: Hold
Price Target
$34.33
+2.0% upside vs current
Range: $30.00 — $38.00
Altman Z
1.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
KMI buys
12
PoliticianChamberTickerTypeAmountDate
Richard W. Allen🏢 House$KMI▲ Buy$1,001 - $15,0002026-02-19
Gilbert Cisneros🏢 House$KMI▲ Buy$1,001 - $15,0002026-02-10
Gilbert Cisneros🏢 House$KMI▼ Sell$1,001 - $15,0002026-01-09
Marjorie Taylor Greene🏢 House$KMI▲ Buy$1,001 - $15,0002025-10-24
Gilbert Cisneros🏢 House$KMI▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$KMI▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$KMI▼ Sell$1,001 - $15,0002025-07-22
Ritchie Torres🏢 House$KMI▼ Sell$1,001 - $15,0002025-07-11
Lisa McClain🏢 House$KMI▲ Buy$1,001 - $15,0002025-07-10
Gilbert Cisneros🏢 House$KMI▲ Buy$1,001 - $15,0002025-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXKMI
Forward yield2.65%3.48%
Annual dividend / share$2.00$1.17
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%12.1%
Portfolio after 10y$23.6K$30.6K
Annual income after 10y$314.03$1,607.93
Total dividends collected$2.9K$8.7K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldHold
Analyst price target$77.80$34.33

Year-by-year: HOLX vs KMI ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrKMI PortfolioKMI Income/yrGap
1← crossover$10,965$264.73$11,090$389.77$125.00KMI
2$12,004$271.27$12,319$452.85$315.00KMI
3$13,121$277.55$13,708$527.01$587.00KMI
4$14,323$283.54$15,282$614.40$959.00KMI
5$15,615$289.27$17,070$717.60$1.5KKMI
6$17,003$294.73$19,104$839.73$2.1KKMI
7$18,493$299.93$21,426$984.61$2.9KKMI
8$20,093$304.87$24,083$1,156.92$4.0KKMI
9$21,809$309.57$27,131$1,362.35$5.3KKMI
10$23,649$314.03$30,638$1,607.93$7.0KKMI

HOLX vs KMI: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

KMIEnergy

Kinder Morgan, Inc. operates as an energy infrastructure company in North America. The company operates through four segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and underground storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas liquefaction and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 83,000 miles of pipelines and 143 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was founded in 1936 and is headquartered in Houston, Texas.

Full KMI Calculator →
📬

Get this HOLX vs KMI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.